Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Travaglino

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|April 4, 2019
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndromeElisa Bono, Donal McLornan, Erica Travaglino, et al.
Blood|June 28, 2014
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasiaLuca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Blood|May 10, 2015
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblastsLuca Malcovati, Mohsen Karimi, Elli Papaemmanuil, et al.
Blood|July 8, 2016
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemiaChiara Elena, Anna Gallì, Esperanza Such, et al.
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood|October 15, 2011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsLuca Malcovati, Elli Papaemmanuil, David T Bowen, et al.
JCO Clinical Cancer Informatics|June 30, 2023
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in HematologySaverio D'Amico, Daniele Dall'Olio, Claudia Sala, et al.
Haematologica|April 26, 2012
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosisJulien Broseus, Lourdes Florensa, Esther Zipperer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic SyndromesCristina Astrid Tentori, Caterina Gregorio, Marie Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|April 4, 2019
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndromeElisa Bono, Donal McLornan, Erica Travaglino, et al.
Blood|June 28, 2014
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasiaLuca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Blood|May 10, 2015
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblastsLuca Malcovati, Mohsen Karimi, Elli Papaemmanuil, et al.
Blood|July 8, 2016
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemiaChiara Elena, Anna Gallì, Esperanza Such, et al.
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood|October 15, 2011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsLuca Malcovati, Elli Papaemmanuil, David T Bowen, et al.
JCO Clinical Cancer Informatics|June 30, 2023
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in HematologySaverio D'Amico, Daniele Dall'Olio, Claudia Sala, et al.
Haematologica|April 26, 2012
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosisJulien Broseus, Lourdes Florensa, Esther Zipperer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic SyndromesCristina Astrid Tentori, Caterina Gregorio, Marie Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Pageof 5